Previous close | 1.76 |
Open | 1.59 |
Bid | 6.15 |
Ask | 8.60 |
Strike | 19.00 |
Expiry date | 2024-07-26 |
Day's range | 1.59 - 10.00 |
Contract range | N/A |
Volume | |
Open interest | 8 |
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the U.S. National Institutes of Health (NIH). Hoau-Yan Wang was a tenured medical professor at a public university’s medical school as well as a former paid science advisor to Cassava Sciences. According to public court documents, Dr. Wang engaged in illegal behavior to defraud the go
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?